ATE396746T1 - Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens - Google Patents
Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchensInfo
- Publication number
- ATE396746T1 ATE396746T1 AT02716134T AT02716134T ATE396746T1 AT E396746 T1 ATE396746 T1 AT E396746T1 AT 02716134 T AT02716134 T AT 02716134T AT 02716134 T AT02716134 T AT 02716134T AT E396746 T1 ATE396746 T1 AT E396746T1
- Authority
- AT
- Austria
- Prior art keywords
- resinate
- formulation
- producing
- quitting smoking
- water
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000000391 smoking effect Effects 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polyesters Or Polycarbonates (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2002/000199 WO2003061709A1 (en) | 2002-01-18 | 2002-01-18 | A method for preparing resinates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396746T1 true ATE396746T1 (de) | 2008-06-15 |
Family
ID=27589640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02716134T ATE396746T1 (de) | 2002-01-18 | 2002-01-18 | Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050169997A1 (de) |
| EP (1) | EP1467769B1 (de) |
| JP (1) | JP4268052B2 (de) |
| CN (1) | CN1615156B (de) |
| AT (1) | ATE396746T1 (de) |
| DE (1) | DE60226899D1 (de) |
| WO (1) | WO2003061709A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005013934A2 (en) * | 2003-07-28 | 2005-02-17 | Novartis Consumer Health S.A. | Taste-masked composition of cationic exchange resin |
| ATE439839T1 (de) * | 2003-12-02 | 2009-09-15 | Fertin Pharma As | Nikotin-abgabeprodukt und herstellungsverfahren |
| DK1890698T3 (da) | 2005-06-01 | 2010-03-29 | Fertin Pharma As | Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt |
| US20070003512A1 (en) * | 2005-06-20 | 2007-01-04 | Stockel Richard F | Bisphosphonate resinates |
| CN117563570B (zh) * | 2024-01-16 | 2024-03-15 | 西安金沃泰环保科技有限公司 | 一种用于蛋白吸附的树脂及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
| DE1617513C3 (de) * | 1965-08-20 | 1974-04-18 | F. Hoffmann-La Roche & Co. Ag, Basel (Schweiz) | Arzneimittelzubereitung |
| NL167303C (nl) * | 1970-07-22 | Leo Ab | Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom. | |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| GB8925484D0 (en) * | 1989-11-10 | 1989-12-28 | Glaxo Group Ltd | Process |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| WO2000040224A1 (en) * | 1999-01-07 | 2000-07-13 | Elan Corporation, Plc | Multiparticulate oral dosage forms |
| US20020032245A1 (en) * | 2000-07-27 | 2002-03-14 | Lyn Hughes | Resinate composition |
| US6607752B2 (en) * | 2000-07-27 | 2003-08-19 | Rohm And Haas Company | Method for the anhydrous loading of nicotine onto ion exchange resins |
| US20020031490A1 (en) * | 2000-07-27 | 2002-03-14 | Bellamy Simon Andrew | Method for preparing resinates |
-
2002
- 2002-01-18 AT AT02716134T patent/ATE396746T1/de not_active IP Right Cessation
- 2002-01-18 EP EP02716134A patent/EP1467769B1/de not_active Expired - Lifetime
- 2002-01-18 WO PCT/GB2002/000199 patent/WO2003061709A1/en not_active Ceased
- 2002-01-18 DE DE60226899T patent/DE60226899D1/de not_active Expired - Lifetime
- 2002-01-18 CN CN028272587A patent/CN1615156B/zh not_active Expired - Lifetime
- 2002-01-18 JP JP2003561651A patent/JP4268052B2/ja not_active Expired - Lifetime
- 2002-01-18 US US10/501,765 patent/US20050169997A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1615156A (zh) | 2005-05-11 |
| WO2003061709A1 (en) | 2003-07-31 |
| DE60226899D1 (de) | 2008-07-10 |
| US20050169997A1 (en) | 2005-08-04 |
| EP1467769A1 (de) | 2004-10-20 |
| JP2005519068A (ja) | 2005-06-30 |
| EP1467769B1 (de) | 2008-05-28 |
| JP4268052B2 (ja) | 2009-05-27 |
| CN1615156B (zh) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020010I1 (no) | fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat | |
| ATE431130T1 (de) | Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe | |
| WO2003051275A3 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
| NZ513356A (en) | Method of modulating metabolite biosynthesis in recombinant cells using an AP2-domain transcription factor that is involved in the response of a plant cell to a jasmonate | |
| GB2415142A (en) | Porous matrix | |
| WO2002069888A3 (en) | Serotonin reuptake inhibitor formulations | |
| NO962126L (no) | Tannpasta med silika-slipemiddel | |
| ATE319702T1 (de) | Verfahren zur herstellung von benzothiophen- derivaten | |
| DE60036029D1 (de) | Basismaterialien zur geweberegeneration, transplantatmaterialien und verfahren zur herstellung selbiger | |
| EP1988253A3 (de) | Verdrehsicherungsspray für Zementierstopfen | |
| EP1458870A4 (de) | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON siRNA, AMPHIPATISCHE VERBINDUNGEN UND POLYKATIONEN | |
| ITMI20030640A1 (it) | Procedimento per l'utilizzo di estratti organici ottenuti per lisciviazione acquosa di legno finalizzato alla preparazione di soluzioni organiche acidificanti per l'agricoltura biologica e concimi ad alta | |
| DE60226899D1 (de) | Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens | |
| ATE375165T1 (de) | Verfahren zur herstellung eines extraktes aus efeublättern | |
| WO2004066984A3 (en) | Improved taste masking pharmaceutical composition and process for its preparation | |
| GB2429206A (en) | Process for the synthesis of hydromorphone | |
| DE60109494D1 (de) | Verfahren zur herstellung von salbutamolisomeren | |
| WO2004054354A3 (en) | Carved pearl | |
| DE60020336D1 (de) | Verfahren zur ausbildung eines konkaven mikroreliefs in einem substrat sowie anwendung des verfahrens zur herstellung optischer komponenten | |
| EA200800966A1 (ru) | Новая композиция, содержащая росиглитазон и другое противодиабетическое средство | |
| ATE478065T1 (de) | Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere | |
| AU6470400A (en) | Nitroxy derivatives of (r) and (s)-carnitine | |
| DE50103950D1 (de) | Verfahren zur Herstellung von Hydrazodicarbonamid (HDC) über Ketimine | |
| AU2003241661A1 (en) | Photosensitizer for generating singlet oxygen and method for generating singlet oxygen | |
| BRPI0407844A (pt) | processo para preparação de formas enancioméricas de derivados de 1,3-ciclohexanodiol com configuração cis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |